3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Keratosis, Actinic
18
Keratosis
3
Condylomata Acuminata
3
Carcinoma, Basal Cell
3
Urinary Bladder Neoplasms
2
Non-Muscle Invasive Bladder Neoplasms
2
Glioblastoma
2
Warts
1
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Virus Diseases
1
Sialorrhea
1
Sexually Transmitted Diseases
1
Papillomavirus Infections
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Glioma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma in Situ
1
Atypical Squamous Cells of the Cervix
1
Adenocarcinoma
1
Interventions
Imiquimod
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Sialorrhea
×
Imiquimod
×
Clear all
NCT02234921
2018-10-11
DRibble
UbiVac
Phase 1
Completed
3 enrolled